Browse studies

Find your next paid study

168 recruiting studies matching your filters

Phase 1 Study of the Safety of an Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

Background: Epstein-Barr virus (EBV) is the primary cause of infectious mononucleosis, commonly known as mono. EBV infects more than 90% of the world s popula…

EBVEpstein-Barr Virus InfectionInfectious Mononucleosis+1 more

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT06908096

Phase 2

Phase II Study Assessing the Effect of BK Specific CTL Lines Generated by Ex Vivo Expansion in Patients With BK Virus Infection and JC Virus Infection

This phase II trial studies how well donor cytotoxic T lymphocytes work in treating patients with malignancies with BK and/or JC virus. Cytotoxic T lymphocytes…

Acquired Immunodeficiency SyndromeBK Virus InfectionHuman Immunodeficiency Virus+5 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT02479698

Observational

PositiveLinks for Youth (PL4Y) for Texas: Effectiveness, Feasibility, and Acceptability of mHealth to Improve Care Outcomes for Young Adults With HIV

The goal of this interventional clinical trial is to test an an app, PL4Y, installed on a mobile smartphone to see if it can help participants aged 18-29 years…

Human Immunodeficiency VirusHIV

Estimated

~$10 – $6,250

The University of Texas Health Science Center at San AntonioNCT07804602

Phase 1

Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

This study is a clinical trial to determine the safety of inoculating G207 (an experimental virus therapy) into a recurrent or refractory cerebellar brain tumo…

Neoplasms, BrainGlioblastoma MultiformeGlioblastoma of Cerebellum+30 more

Estimated

~$10 – $6,250

Phase 3

COVE-3: A Phase 3, Double-blind, Randomized, Vehicle-controlled Study to Evaluate the Efficacy and Safety of YCANTH (VP-102/TO-208) in Subjects With Common Warts (Verruca Vulgaris)

This is a Phase 3, double-blind, randomized, vehicle-controlled study (Study number VP-CW-302; referred to as COVE-3 \[Cantharidin and Occlusion in Verruca Epi…

Common WartsCommon Warts (Verruca Vulgaris)Human Papilloma Virus (HPV)+1 more

Estimated

~$10 – $8,750

Verrica Pharmaceuticals Inc.NCT07637734

Observational

Project ARTEMIS: A Mechanistic Clinical Trial of Neuroimmune Pathways.

The purpose of this research is to understand how chronic stress affects the way our brain and immune systems function, and in turn how this affects the way pe…

Stimulant UseHuman Immunodeficiency Virus (HIV)Depression

Estimated

~$10 – $6,250

Wake Forest University Health SciencesNCT06814275

Observational

TweenVax: A Comprehensive Practice-, Provider-, and Parent/Patient-Level Intervention to Improve Adolescent HPV Vaccination

This clinical trial compares the effect of a vaccine promotional intervention, TweenVax, to standard of care vaccination promotion practices on rates of human …

Human Papillomavirus-Related Carcinoma

Estimated

~$10 – $6,250

Emory UniversityNCT07104240

Phase 4

A Multi-Center, Single-Arm, Open-Label, Prospective, Phase 4 Study to Investigate the Safety and Efficacy of Rapidly Restarting Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Viremic and Virologically-Suppressed Male and Female HIV-Positive Patients Aged ≥18 Years Who Are Treatment-Experienced and Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks

Managing HIV well requires taking antiretroviral therapy (ART) every day, but many people living with HIV experience interruptions in their treatment. These pa…

HIV -1 InfectionHIV (Human Immunodeficiency Virus)HIV+1 more

Estimated

~$10 – $7,500

CAN Community HealthNCT07476339

Phase 1

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Higher Dose of the HCMV-HIV Vaccine Candidate VIR-1388, in HCMV-seropositive Adult Participants Without HIV

This study is to test an experimental HIV Vaccine. About 12 participants, aged 18-55 years and who already have cytomegalovirus (CMV) will take part in this st…

Cytomegalovirus (CMV)HIV (Human Immunodeficiency Virus)

Estimated

~$10 – $5,625

National Institute of Allergy and Infectious Diseases (NIAID)NCT07801456

Phase 3

Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy

The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-ass…

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more

Estimated

~$10 – $7,500

Pierre Fabre MedicamentNCT03394365

Phase 1

A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)

This is a Phase Ib in adult patients with relapsed or refractory EBV-positive DLBCL using daily oral dosing of VK-2019 in three dose escalation cohorts: 600 mg…

Diffuse Large B Cell Lymphoma RefractoryDiffuse Large B Cell Lymphoma RelapsedEpstein-Barr Virus (EBV) Infection

Estimated

~$10 – $7,500

Pierluigi PorcuNCT06789159

C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States

The purpose of the CASCADE-3002 project is to improve access to cervical cancer screening among women with Human Immunodeficiency Virus (HIV) receiving care at…

Human Immunodeficiency Virus (HIV)Human Papillomavirus (HPV)Cervical Cancer+1 more

Estimated

~$10 – $750

UNC Lineberger Comprehensive Cancer CenterNCT07520188